Pharma News - Chemdiv

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health con...

Nektar Shares Halve on Cancer Trial Failure

Biotech Nektar Therapeutics and its partner Bristol Myers Squibb said early Monday that their cancer drug known as bempeg had failed in a trial in melanoma patients. ...

Are statin side effects all in the mind? International experts recommend ways to improve adherence to statin therapy

For the first time, an international group of experts has issued recommendations to doctors about how to distinguish between true side effects caused by statins that have been prescribed in order ...

Ready, set…GO! Scientists discover a brain circuit that triggers the execution of planned movement

The discovery, published in the scientific journal Cell, results from a collaboration of scientists at the Max Planck Florida Institute for Neuroscience, HHMI's Janelia Research Campus, the Allen ...

Is it 'Pre-Alzheimer's' or normal aging? Poll finds many Americans unclear

You regularly can't remember where you left your phone or your book. You keep missing appointments. You often lose your train of thought during conversation.

FDA declines approval for AstraZeneca’s chronic rhinosinusitis antibody

The US Food and Drug Administration (FDA) has declined to grant approval to AstraZeneca’s Fasenra (benralizumab) to treat individuals with inadequately controlled chronic rhinosinusitis with nasa...

FDA grants fast track designation to donor-derived CAR-T for advanced kidney cancer

The FDA granted fast track designation to ALLO-316, an investigational chimeric antigen receptor T-cell therapy, for the treatment of adults with advanced or metastatic clear cell renal cell carcinoma...

Pfizer concludes Arena Pharmaceuticals acquisition for $6.7bn

Pfizer will gain access to Arena’s portfolio of various treatment candidates for gastroenterology, dermatology and cardiology.

FDA approves olaparib for adjuvant treatment of high-risk early breast cancer

On March 11, 2022, the Food and Drug Administration approved olaparib (Lynparza, AstraZeneca Pharmaceuticals, LP) for the adjuvant treatment of adult patients with deleterious or suspected deleter...

Scientists identify possible new treatment for COVID-19

Investigators at Cedars-Sinai have identified a potential new therapy for COVID-19: a biologic substance created by reengineered human skin cells.

Oral paratyphoid vaccine to begin human trials

The University of Oxford in collaboration with the University of Maryland School of Medicine (UMSoM) has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in ...

Researchers re-engineer red blood cells to trigger immune system against COVID-19

Physicists, chemists and immunologists at McMaster University have teamed up to modify red blood cells to transport viral agents which can safely trigger the immune system to protect the body again...

Pharma News, 2022